Andrei V. Krivtsov

11.4k citations

49 papers · 5.7k indexed · 4 hit papers · h-index 28

Impact in

Hematology top 0.2%
- Acute Myeloid Leukemia Research
Molecular Biology top 1%
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
- Genomics and Chromatin Dynamics
- RNA modifications and cancer

Papers in

Hematology 28
- Acute Myeloid Leukemia Research 28
Molecular Biology 39
- Epigenetics and DNA Methylation 17
- Protein Degradation and Inhibitors 10
- Cancer-related gene regulation 9
- Genomics and Chromatin Dynamics 8
- RNA Interference and Gene Delivery 5
- Histone Deacetylase Inhibitors Research 4

Co-authors: Scott A. Armstrong Joerg Faber Amit Sinha Matthew C. Stubbs Zhaohui Feng Andrew L. Kung William C. HahnJing Wang
Journals: Blood (18 papers)Cancer Cell (3 papers)Clinical Cancer Research (2 papers)Nature Communications (2 papers)Leukemia (2 papers)
Partner nations: United States Germany Netherlands

In The Last Decade

Andrei V. Krivtsov

48 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L 2011 · 642 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Cancer Cell
2010 Science
2007 Nature reviews. Cancer
2006 Nature

Peers

Countries citing papers authored by Andrei V. Krivtsov

Since Specialization

Citations

This map shows the geographic impact of Andrei V. Krivtsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei V. Krivtsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei V. Krivtsov more than expected).

Fields of papers citing papers by Andrei V. Krivtsov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrei V. Krivtsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei V. Krivtsov. The network helps show where Andrei V. Krivtsov may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrei V. Krivtsov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrei V. Krivtsov Line = papers co-authored together Andrei V. Krivtsov links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia Science ·Hannah J. Uckelmann, Harshita A. Gawad, Eric Wong, Charlie Hatton, Hugh Giovinazzo, Jayant Y. Gadrey, Andrei V. Krivtsov, Frank G. Rücker, Konstanze Döhner, Gerard M. McGeehan, Ross L. Levine, Lars Bullinger, George S. Vassiliou, Scott A. Armstrong	2020	152
2	LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML Blood ·Monica Cusan, Sheng F. Cai, Helai P. Mohammad, Andrei V. Krivtsov, Alan Chramiec, Evangelia Loizou, Matthew D. Witkin, Kimberly N. Smitheman, Daniel G. Tenen, Min Ye, Britta Will, Ulrich Steidl, Ryan G. Kruger, Ross L. Levine, Hugh Young Rienhoff, Richard P. Koche, Scott A. Armstrong	2018	81
3	IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation Cell stem cell ·Sun‐Mi Park, Hyunwoo Cho, Angela M. Thornton, Trevor Barlowe, Timothy Chou, Sagar Chhangawala, Lauren Fairchild, James Taggart, Arthur Chow, Alexandra Schurer, Antoine Gruet, Matthew D. Witkin, Jun Hyun Kim, Ethan M. Shevach, Andrei V. Krivtsov, Scott A. Armstrong, Christina S. Leslie, Michael G. Kharas	2018	65
4	Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by Mll-Af4 and activated Ras Blood Advances ·S. Haihua Chu, E Song, Jonathan Chabon, 杨平松, 潘学英, S. MUTTAMARA, Elizabeth S. Frank, Kenneth N. Ross, Richard P. Koche, Zhaohui Feng, Haiming Xu, Andrei V. Krivtsov, André Nussenzweig, Scott A. Armstrong	2018	13
5	A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription Molecular Cell ·Shu‐Ping Wang, Zhanyun Tang, Chun‐Wei Chen, Miho Shimada, Richard P. Koche, Lan-Hsin Wang, Tomoyoshi Nakadai, Alan Chramiec, Andrei V. Krivtsov, Scott A. Armstrong, Robert G. Roeder	2017	149
6	ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia Nature Communications ·和弘安福, Alessandro Pastore, Daichi Inoue, Nicolas Duployez, Eun Hee Kim, Stanley Chun-Wei Lee, Benjamin H. Durham, Young Rock Chung, Hana Cho, Elisa Maria Faria Guedes, Akihide Yoshimi, Andrei V. Krivtsov, Richard P. Koche, Éric Solary, Amit Sinha, Claude Preudhomme, Omar Abdel‐Wahab	2017	46
7	Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL Clinical Cancer Research ·Matthew C. Stubbs, Won-Il Kim, К. П. Нечипоренко, Tina Davis, Sridhar Vempati, 杨平松, Matthew D. Witkin, Jun Qi, Andrei V. Krivtsov, James E. Bradner, Andrew L. Kung, Scott A. Armstrong	2015	59
8	A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescence Genes & Development ·Gerard L. Brien, Evan Healy, Emilia Jerman, Eric Conway, Elisa Fadda, V. Michailova, Andrei V. Krivtsov, Alan M. Rice, Conor J. Kearney, Andrew Flaus, Simon S. McDade, Séamus J. Martin, Aoife McLysaght, David O’Connell, Scott A. Armstrong, Adrian P. Bracken	2015	27
9	Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia Cell stem cell ·Min Ye, Hong Zhang, Henry Yang, Richard P. Koche, Philipp B. Staber, Monica Cusan, Elena Levantini, Robert S. Welner, Christian Bach, Junyan Zhang, Andrei V. Krivtsov, Scott A. Armstrong, Daniel G. Tenen	2015	78
10	AF10 Regulates Progressive H3K79 Methylation and HOX Gene Expression in Diverse AML Subtypes Cancer Cell ·Aniruddha J. Deshpande, Anagha Deshpande, Amit Sinha, Liying Chen, Jenny C. Chang, Kaya TOKMAKCİOGLU, Maurizio Fazio, Chun‐Wei Chen, Nan Zhu, Richard P. Koche, Thomas H. Tsai, Z Zhang, Monica Samuelsen, Deepti Banka, Andrei V. Krivtsov, Minkui Luo, R G Roeder, James E. Bradner, Kathrin M. Bernt, Scott A. Armstrong	2014	132
11	Pathprinting: An integrative approach to understand the functional basis of disease Genome Medicine ·Gabriel Altschuler, Oliver Hofmann, Irina Kalatskaya, Emile Minyaka, Shannan J. Ho Sui, Lai Xuan, Andrei V. Krivtsov, Scott A. Armstrong, Tianxi Cai, Lincoln Stein, (unknown)	2013	12
12	Cell of origin determines clinically relevant subtypes of MLL-rearranged AML Leukemia ·Andrei V. Krivtsov, María E. Figueroa, Amit Sinha, Matthew C. Stubbs, Zhaohui Feng, Peter J.M. Valk, Robert M.G. Hynson, Konstanze Döhner, Lars Bullinger, Andrew L. Kung, Ari Melnick, Scott A. Armstrong	2012	150
13	The Stem Cell Discovery Engine: an integrated repository and analysis system for cancer stem cell comparisons Nucleic Acids Research ·Shannan J. Ho Sui, Kimberly Begley, Dorothy Reilly, Brad Chapman, Patricia Cherin, Aurélio Campos Maciel, Eamonn Maguire, Gabriel Altschuler, 杨秋莎, Ramakrishna Sompallae, Andrei V. Krivtsov, Ramesh A. Shivdasani, Scott A. Armstrong, Aedín C. Culhane, Mick Correll, Susanna‐Assunta Sansone, Oliver Hofmann, (unknown)	2011	19
14	MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L Cancer Cell ·Kathrin M. Bernt, Nan Zhu, Amit Sinha, Sridhar Vempati, Joerg Faber, Andrei V. Krivtsov, Zhaohui Feng, 介晓阳, Liu Lvfeng, Lars Bullinger, Roy M. Pollock, Victoria M. Richon, Andrew L. Kung, Scott A. Armstrong Hit paper breakdown →	2011	642
15	The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML Science ·Jenny Wang, Andrei V. Krivtsov, Amit Sinha, Trista E. North, Wolfram Goessling, Zhaohui Feng, Leonard I. Zon, Scott A. Armstrong Hit paper breakdown →	2010	564
16	MLL -Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1 Clinical Cancer Research ·Przemysław Juszczyński, Scott J. Rodig, Jing Ouyang, Evan A. O’Donnell, Kunihiko Takeyama, Wojciech Młynarski, Flavio Quessada, Tomasz Szczepański, Lu Taian, Andrei V. Krivtsov, Joerg Faber, Amit Sinha, Gabriel A. Rabinovich, Scott A. Armstrong, Jeffery L. Kutok, Margaret A. Shipp	2010	28
17	Transformation from Committed Progenitor to Leukemia Stem Cells Annals of the New York Academy of Sciences ·Andrei V. Krivtsov, Zhaohui Feng, Scott A. Armstrong	2009	16
18	H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias Cancer Cell ·Andrei V. Krivtsov, Zhaohui Feng, Madeleine E. Lemieux, Joerg Faber, Sridhar Vempati, Amit Sinha, Xiaobo Xia, Jonathan L. Jesneck, Adrian P. Bracken, Lewis B. Silverman, Jeffery L. Kutok, Andrew L. Kung, Scott A. Armstrong	2008	396
19	Jedi—a novel transmembrane protein expressed in early hematopoietic cells Journal of Cellular Biochemistry ·Andrei V. Krivtsov, Qixiao Wu, M. V. Zinovyeva, Maria Luissa Schemann, Yajuan Jiang, Jan Visser, A. V. Belyavsky	2007	20
20	Both SH2 Domains Are Involved in Interaction of SHP-1 with the Epidermal Growth Factor Receptor but Cannot Confer Receptor-directed Activity to SHP-1/SHP-2 Chimera Journal of Biological Chemistry ·Tencho Tenev, Heike Keilhack, Siniša Tomić, HE Zhie, Matthias Stein-Gerlach, Reiner Lammers, Andrei V. Krivtsov, Axel Ullrich, Frank‐D. Böhmer	1997	81

About Andrei V. Krivtsov

Andrei V. Krivtsov is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Cancer Research, having authored 49 papers that have together received 5.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Epigenetics and DNA Methylation (17 papers), Protein Degradation and Inhibitors (10 papers), Cancer-related gene regulation (9 papers), Genomics and Chromatin Dynamics (8 papers), RNA Interference and Gene Delivery (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Hematology (2.6k citations), Molecular Biology (4.6k citations), Genetics (427 citations), Cancer Research (604 citations) and Oncology (885 citations). Andrei V. Krivtsov has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Scott A. Armstrong, Joerg Faber, Amit Sinha, Matthew C. Stubbs, Zhaohui Feng, Andrew L. Kung, Zhaohui Feng, William C. Hahn, Jing Wang and Todd R. Golub. Their work appears in journals such as Blood, Cancer Cell, Clinical Cancer Research, Nature Communications and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact